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Abstract
Background: Megakaryocytes (MKs) originate from cells immuno- phenotypically 
indistinguishable from hematopoietic stem cells (HSCs), bypassing intermediate pro-
genitors. They mature within the adult bone marrow and release platelets into the 
circulation. Until now, there have been no transcriptional studies of primary human 
bone marrow MKs.
Objectives: To characterize MKs and HSCs from human bone marrow using single- 
cell RNA sequencing, to investigate MK lineage commitment, maturation steps, and 
thrombopoiesis.
Results: We show that MKs at different levels of polyploidization exhibit distinct tran-
scriptional states. Although high levels of platelet- specific gene expression occur in the 
lower ploidy classes, as polyploidization increases, gene expression is redirected toward 
translation and posttranslational processing transcriptional programs, in preparation 
for thrombopoiesis. Our findings are in keeping with studies of MK ultrastructure and 
supersede evidence generated using in vitro cultured MKs. Additionally, by analyzing 
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1  |  INTRODUC TION
Megakaryocytes (MKs) comprise <0.01% of all nucleated cells in the 
human bone marrow. These are large, fragile, up to 150 μm in diam-
eter, and highly polyploid (average 16 N) cells.1 The current knowledge 
about their transcriptional landscape is largely based on gene expres-
sion array data of in vitro differentiated MKs cultured from CD34+ cells 
obtained from fetal liver, cord blood, and adult blood; all having an av-
erage ploidy of 2 N and with severely constrained capacity for platelet 
production.2- 6 It is therefore likely that some drivers of differentiation, 
ploidy change, and maturation of in vivo MKs are yet to be identified.
MK differentiation from hematopoietic stem cells (HSCs) via the 
classic route of intermediate progenitors has been challenged and 
been shown that they can originate directly from the multipotent 
HSC compartment as the first lineage bifurcation.7- 11 Lineage tracing 
experiments have established a direct HSC origin, independent from 
other lineages, for at least one- half of all MKs.12 MK- primed HSCs 
have been identified in mouse by their expression of genes for the 
coagulation protein von Willebrand factor13 and glycoprotein (GP) 2b 
(CD41) of the integrin receptor for fibrinogen (integrin alpha2- beta).14
The primary physiological function of MKs is thrombopoiesis, 
where each cell produces up to 6000 platelets that play a pivotal role 
in hemostasis. During steady- state thrombopoiesis, the circulating 
platelet mass is maintained constant and an inverse relationship 
between platelet count and volume exists.15 Platelet consumption 
results in the acute release of larger platelets to maintain overall 
circulating platelet mass and aberrations in platelet count and func-
tion result in thrombotic or bleeding disorders.16 Evidence suggests 
that stemlike MK- committed progenitors are activated upon acute 
inflammatory stress.17 Moreover, sepsis drives changes in tran-
scription and translation in platelets and transcriptional changes 
in murine MKs.18 Stress thrombopoiesis is also thought to occur in 
myocardial infarction, based on the observation of elevated mean 
platelet volume and reticulated platelet fraction in the acute setting 
suggesting an upregulation of the HSC– MK axis.19
Here, we characterize MKs and HSCs from human bone marrow, 
down to single- cell resolution, by full- transcript RNA sequencing. 
Primary MK transcriptome analysis showed that low ploidy states 
have a high expression of archetypal platelet genes, which are then 
downregulated as the ploidy increases in favor of genes implicated 
in translation and protein localization. The origin of MKs was also 
investigated by performing single- cell RNA sequencing of human 
bone marrow HSCs from the same individuals. Within the HSC 
compartment, we identified two subpopulations of cells represent-
ing MK- primed HSCs. Finally, by sequencing MKs from individuals 
undergoing coronary artery bypass grafting following myocardial 
infarction, we showed changes in primary MK gene expression sup-
porting a role for stress thrombopoiesis in this pathological state.
2  |  METHODS
2.1  |  MK and HSC isolation
Bone marrow for HSC and MK sorting was obtained from individu-
als undergoing cardiac surgery at Barts Health NHS Trust, London, 
after informed consent and ethical approval from London - City & 
East, REC 13/LO/1760 (BAMI Platelet Sub- study). Inclusion criteria 
transcriptional signatures of a single HSC, we identify two MK- biased HSC subpopula-
tions exhibiting unique differentiation kinetics. We show that human bone marrow 
MKs originate from these HSC subpopulations, supporting the notion that they display 
priming for MK differentiation. Finally, to investigate transcriptional changes in MKs 
associated with stress thrombopoiesis, we analyzed bone marrow MKs from individu-
als with recent myocardial infarction and found a specific gene expression signature. 
Our data support the modulation of MK differentiation in this thrombotic state.
Conclusions: Here, we use single- cell sequencing for the first time to characterize 
the human bone marrow MK transcriptome at different levels of polyploidization and 
investigate their differentiation from the HSC.
K E Y W O R D S
megakaryocytes, hematopoietic stem cells, platelets, single cell RNA- seq, thrombosis
Essentials
• Full transcript single cell RNA sequencing of primary human megakaryocytes and hematopoi-
etic stem cells.
• Megakaryocyte of different ploidy levels exhibit distinct transcriptional states.
• Two megakaryocyte- biased hematopoietic stem cell populations were identified.
• Megakaryocytes from individuals with myocardial infarction exhibit a specific gene signature.
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were: (1) heart valve replacement with no evidence of coronary 
artery disease on coronary angiography or (2) coronary artery by-
pass grafting in the context of recent myocardial infarction (within 
6 months). Myocardial infarction was defined as acute presentation 
with chest pain, deviation of ST segments on electrocardiogram 
(either ST elevation myocardial infarction or non- ST elevation myo-
cardial infarction), and rise in levels of troponin T assay. Exclusion 
criteria were: presence or history of hematological malignancy 
and abnormal platelet count and hemoglobin levels <85 g/L. Bone 
marrow scrapings following median sternotomy were collected 
into an ethylenediaminetetraacetic acid Vacutainer tube contain-
ing Dulbecco's phosphate buffered saline containing 10% human 
serum albumin.
Red cells were lysed using ammonium chloride lysis. MKs were 
stained with anti- CD41a- APC, anti- CD42b- PE, and 1 μg/ml Hoechst 
33342. Cells were sorted as single MKs defined as CD41Hi, CD42Hi, 
and 2 N to 32 N by Hoechst staining using a FACSAria Fusion flow 
sorter. From each bone marrow sample, the approximate nucleated 
cell count was 1 × 106 cells. To assess changes in MK transcriptome 
with increasing ploidy level, MKs were single cell– sorted as single 
cells and 20 cell pools according to their ploidy level, which was 
determined by level of Hoechst staining. To assess changes in MK 
transcriptome between disease (myocardial infarction) and noncoro-
nary artery disease (non- CAD) control groups MKs were single cell– 
sorted in 50- to 100- cell pools; here, sorting was performed on all 
MKs without separation by ploidy level, thereby representing with 
the full distribution of MK ploidy observed. Because of the size of 
MKs (up to 100 μM) a 150- μM nozzle was used for fluorescence- 
activated cell sorting (FACS). HSCs were stained with anti- Lin- PECy5 
(CD2, CD3, CD10, CD11b, CD11c, CD19, CD20, CD56, CD42b, GP6), 
anti- CD34- AF700, anti- CD38- PerCP- Cy5.5, anti- CD90- PECy7, anti- 
CD49f- PE, and anti- CD45RA- PB. Cells were sorted as single HSCs 
defined as Lineage- , CD34+, CD38- , CD45RA- , CD90+, and CD49f+ 
using a FACSAria Fusion flow sorter. Index sort data were collected 
for each single cell.
2.2  |  RNA sequencing and computational analysis
Single- cell libraries were prepared using the G&T- seq protocol20 and 
the Illumina Nextera XT DNA preparation kit. ERCC spike- in RNA 
(Ambion) was added before library preparation. Equal quantities of 
complementary DNA (cDNA) were used from each single cell or cell 
pool. Pooled libraries were sequenced by 125- bp paired- end on the 
Illumina HiSeq 4000 instrument using TruSeq reagents (Illumina). 
Adapters were trimmed <32 bp using TrimGalore! Reads were 
mapped to the human reference genome (GRCh37) using STAR.21 
Quality metrics were assessed for each sample. Expression in all 
cases was normalized to library size and ERCC spike- ins.
For HSCs, low- quality cells were filtered using a previously de-
scribed support vector machine (SVM) approach22 and HSC cDNA- 
positive for GAPDH. For MKs, filtering of low- quality cells was 
performed using the same features, but in a five- round training of 
random forest models.23 The most highly variable genes were fil-
tered above technical noise using the Scater package24 using previ-
ously described methods.25 ERCC spike- ins were used to model the 
trend in technical variability.26
For both HSC and MK single cells, unsupervised clustering of 
single cells was performed in a principal component analysis (PCA) 
with robustness of clusters determined by the Silhouette index.27 
Using SC3, cluster marker genes were identified based on their pre-
dictive value to separate each cluster from the rest with a p value 
(<0.001) determined using the Wilcoxon signed- rank test.28 Cells 
were ordered into differentiation trajectories using the Monocle 
2 single- cell analysis toolset29,30 using five clusters, a maximum of 
three dimensions, and otherwise default parameters.
To assess expression of known hematopoietic gene signatures 
within single- cell clusters, gene signatures for each cell type in the 
DMAP dataset31 were created using the LIMMA package.32 Genes 
that were considered to be part of the gene signature log2 fold 
change of >1 and false discovery rate (FDR) <0.05. DESeq233 was 
used to find genes that were differentially expressed between dif-
ferent datasets in single MKs and MK pools with comparisons made 
between 4 N and 32 N ploidy levels or between disease and non- 
CAD control. Here, the Wald test was used for hypothesis testing. 
Differentially expressed genes (significantly upregulated or down-
regulated) were defined as p < .05. Size factors were estimated by 
scran.34 Gene ontology (GO) analysis was performed using Fidea35 
(http://circe.med.uniro ma1.it/fidea).
FACS data from a previous study by Belluschi et al.36 were 
used in PCA analysis on scaled data (PCA_B), onto which new sam-
ples (BM_HSC) were projected by applying PCA_B scaling target 
and center. The position was calculated as adot- product of scaled 
BM_HSC vector and PCA_B rotation. Cells were marked according 
to differentiated cell type, where cell type perimeter is shown via 
geom_encircle (https://CRAN.R- proje ct.org/packa ge=ggalt) using 
parameters s_shape = 0.6 and expand = 0.1.
2.3  |  Data- sharing statement
All RNA- sequencing (RNA- seq) data have been deposited in the 
European Genome- phenome Archive under accession number 
EGAS00001004844.
F I G U R E  1  Primary human bone marrow MK sorting strategy. Fluorescence- activated cell sorting. Antibody stains used: PECy5 
conjugated anti- CD42, APC conjugated anti- CD41, Hoechst 33342. Total bone marrow cells after red cell lysis were sorted as single cells 
and then identified as CD41+CD42+. Ploidy plot of this population detecting levels of Hoechst 33342 staining showing typical ploidy 
distribution for human bone marrow MKs. Cells were sorted as 2 N, 4 N, 8 N, 16 N, 32 N, with MKs being defined as 4 N- 32 N in case of 
contamination of other 2 N cells. Number of 20 cell pools for each ploidy class: 2 N: n = 3; 4 N: n = 6; 8 N: n = 7; 16 N: n = 8; and 32 N: n = 8. 
MK, megakaryocyte 
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3  |  RESULTS
3.1  |  Human bone marrow megakaryocyte gene 
expression varies with ploidy level
To characterize the transcriptome of bone marrow– residing MKs, 
as well as, the transcriptional changes associated with increased 
ploidy, we isolated MKs from bone marrow scrapings obtained 
from individuals. Ploidy distribution analysis by flow cytometry 
was consistent with previous descriptions of ex vivo MKs1,16,37 
(Figure 1A). We sequenced 32 pools of 20 MKs and 1106 single 
MKs with ploidy ranging from 2 N to 32 N, isolated from 10 in-
dividuals undergoing sternotomy for heart valve replacement 
(Table S1). Thirty- two pools of 20 MKs were sorted according to 
ploidy from five individuals and sequenced. The number of pools 
for each ploidy group were: 2 N: n = 3; 4 N: n = 6; 8 N: n = 7; 16 N: 
n = 8; and 32 N: n = 8, with at least one pool from each individual 
in each ploidy group except 2 N. The 125- bp paired- end sequenc-
ing was performed at a depth of approximately 500 million reads/
sample. A total of 1106 single MKs were sorted from a further five 
individuals: 2 N: n = 220; 4 N: n = 158; 8 N: n = 200; 16 N: n = 272; 
and 32 N: n = 256. The 125- bp paired- end sequencing was per-
formed at an approximate depth of 50 million reads/sample. Low- 
quality single cell samples were filtered with a five- round training 
scheme of random forest models23 trained on the 20 cell MK pools 
(Figure S1). A total of 282 single MKs (equally spread between 
ploidy levels) were taken forward for transcriptome analysis based 
on quality control measures.
The MK transcriptome was analyzed in two separate ways. 
First, we inspected the highly expressed genes. Among those, 
we found enrichment for mitochondrial and cell metabolism 
genes such as MT- RNR1, MT- RNR2, and CYTB and the gene en-
coding cyclooxygenase- 1 (PTGS1), the protein acetylated by as-
pirin (Table S2), as previously described in platelet transcriptome 
studies.38 In the 100 highest expressed genes from MK pools 
sorted by ploidy level, we observed largely a bimodal distri-
bution in expression, 15 genes were mostly expressed in 4 N 
and 8 N MKs and were enriched GO terms related to platelet 
function (Table S3– S8). A second group of genes (n = 40) were 
mostly expressed in 16 N and 32 N cells; these were enriched 
for GO terms associated with translation and protein processing 
(Figure 2A). Because of these differences, we performed dif-
ferential gene expression analysis between 4 N and 32 N MK 
pools, as well as single cells (Tables S9– S12). This identified 944 
differentially expressed genes (DEG), 571 were upregulated in 
4 N MK pools compared with 32 N (FDR <0.05, 179 DEG with 
an FDR <0.0001), whereas 373 were upregulated in 32 N cells 
compared with 4 N (FDR <0.05; 181 DEG with an FDR <0.0001). 
GO terms enrichment analysis found GO terms associated with 
platelet degranulation, coagulation, hemostasis, wound healing, 
and vesicle- mediated transport in the lower ploidy MK transcrip-
tome, whereas, with increasing polyploidization, we found GO 
terms related to translational initiation, elongation and termi-
nation, protein localization, and cellular protein complex disas-
sembly (Figure 2B and Tables S13, S14). Comparable results were 
found in the single- cell differential gene expression/GO analysis 
(Tables S15, S16).
To investigate signals from the bone marrow niche that might 
contribute to MK maturation in vivo, we annotated genes upregu-
lated with accumulating ploidy in terms of their subcellular localiza-
tion using the Ensembl database39 (Table 1). Of the 373 upregulated 
genes, 78 contained transmembrane domains and most localized to 
the cell membrane. Although these have a wide range of functions, 
a number of them encode for transmembrane proteins, including: 
the G protein– coupled receptor PTGER2, the tetraspanin CD63, the 
tumor necrosis factor (TNF)- alpha receptor TNFRSF1B and lyso-
phosphatidic acid receptor PPAP2A. PTGER2, TNFRSF1B, and P2Y6 
encoding for the pyrimidine nucleotide receptor P2Y6, genes encod-
ing for cytokine receptors IL13RA1 and IL15RA as well as the com-
plement receptor CR1 are highly enriched with increasing MK ploidy 
(FDR <1E- 8). Seventy- two of 78 genes have low levels of expression 
in previously published datasets of in vitro– cultured MKs,6 where 
the MKs are usually of ploidy levels 2 N to 4 N (Figure S1C).
3.2  |  MK lineage priming in ex vivo human bone 
marrow HSCs
To investigate the origin of MKs and gain insight into megakary-
opoiesis in vivo, we characterized the HSC transcriptional land-
scape and early fate commitment events. We sequenced 884 
single phenotypic HSCs (CD34+ CD38- CD45RA- CD90+ CD49f+ 
[Figure S2], the compartment most enriched in long- term repopu-
lating HSCs9) isolated from fresh bone marrow harvested from a 
further five individuals undergoing sternotomy for heart valve re-
placement (Table S17). We demonstrated that these phenotypic 
HSCs do contain cells able to confer long- term hematopoietic re-
constitution (Supplementary Methods and Table S19). From the 
sequenced HSCs, raw reads were filtered to exclude cells that 
gave low- quality libraries (Figure S3) with a SVM learning method 
trained on a subset of samples made from cDNA positive for 
GAPDH, as measured by quantitative reverse transcriptase pol-
ymerase chain reaction (Table S18). Nineteen single HSCs were 
taken forward for transcriptome analysis based on quality control 
measures.
To identify subpopulations of cells within the HSC compartment, 
we used unsupervised hierarchical clustering of the cells’ Pearson 
correlation coefficients in the PCA space to generate clusters 
(Figure 3A) where total silhouette score was used to select the num-
ber of clusters tested (Figure S4A). The robustness of our clustering 
strategy was confirmed by inspecting the first four principal com-
ponents (Figure S4B,C). The cells within the HSC population formed 
five distinct clusters. Marker genes for each cluster were then iden-
tified based on their predictive value to separate that cluster from 
    |  1241CHOUDRY et al.
F I G U R E  2  Development and polyploidization of bone marrow residing MKs. (A) Number of genes expressed related to specific GO terms 
at each MK ploidy level; data shown based on 100 most abundantly expressed genes. GO terms: platelet activation, blood coagulation, 
response to wounding, translation, protein localization. The full GO analysis may be found in Table S10– S14. (B) Two distinct transcriptional 
states in MK differentiation. Upper panel: Overrepresented GO terms in downregulated and upregulated genes with increasing ploidy, 
data shown are based on differential expression analysis between 32 N and 4 N MK 20 cell pools. Full GO analysis may be found in Tables 
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the remaining cells (Wilcoxon rank test, p < 0.001). The expression 
of the top 20 genes characterizing each cluster shows distinct ex-
pression patterns independently of donor; of note, cluster 3 had no 
significant marker genes (Figure 3B and Table S20 for the full list of 
genes). Many of the marker genes for clusters 1 and 4 were found 
to be highly expressed in previously reported MK datasets.6 Cluster 
1 cells were marked by the expression of genes known to be highly 
expressed in all MK precursors (HSC, multipotent progenitors, com-
mon myeloid progenitor, MK- erythroid precursor) such as PRKACB, 
NRIP1, PARP1, HEMGN, as well as ANGPT1 and IL1b, which encode 
proteins directly involved in platelet function. By contrast, cluster 
4 cells were characterized only by genes encoding proteins directly 
involved in platelet function such as: TUBB1, TUBA4A, F13A1, CCL5, 
PTCRA, and GRAP2 (Table S20).
Cluster 1 transcriptome appears to have an ontological bias to-
ward translation, ribosomal function and protein localization, cellular 
metabolism, coagulation, and hemostasis. Cluster 2 marker genes ap-
pear to have an ontological bias toward angiogenesis, endothelial cell 
function, and wound healing. The overrepresented GO categories 
for cluster 4 are related to negative regulation of cell death/apopto-
sis, cell- cycle, protein folding, and exocytosis, whereas the cluster 5 
gene signature showed overrepresentation of categories related to 
immunity and leukocyte function. The full GO analysis is found in 
Tables S21– S24, overrepresented GO categories identified using a 
significance cutoff of p < .05.
3.3  |  Developmental trajectories of early MK 
lineage priming in HSCs
To investigate if HSCs exhibited lineage priming potential, we per-
formed trajectory analysis, independent of the previous clustering, 
using Monocle2.30 We obtained potential developmental trajectories 
and five clusters, very similar to the previous ones, were found. This 
analysis showed two distinct branching points, with clusters 1 and 
4 stemming from the same developmental trajectory (Figure 4A). 
To determine whether these trajectories could delineate early fate 
priming in HSC, we derived gene signatures from the highly purified 
hematopoietic populations in a previously published study31 and visu-
alized these signatures onto the trajectory plot. The signature for MK 
was found enriched in cells localized around branching point 2 and 
belonging to clusters 1 and 4 (Figure 4B), whereas the gene expres-
sion signature for the megakaryocyte erythroid progenitor (MEP) was 
found enriched only in cells belonging to cluster 1 after the branching 
point 2 (Figure 4C). These signatures are largely not overlapping and 
no single gene appears to drive enrichment (Figure S5).
To investigate where the mature MKs transcriptionally fell in 
terms of differentiation, we added 188 MK pools from 20 individ-
uals undergoing median sternotomy for cardiac surgery to the HSC 
trajectory analysis discussed previously using Monocle2.30 The ad-
dition of mature MK transcriptional signatures to the HSC develop-
mental trajectories showed that these are most similar to and branch 
TA B L E  1  MK transcripts upregulated with ploidy: localization within the cell.
Localization Significantly Upregulated Genes in 32 N MK Pools Compared with 4 N
Cell membrane UNC80, ENPEP, PTGER2, TMPRSS7, ASGR2, KCNK5, CACNA2D1, P2RY6, NTRK3, SLC52A3, ADCY5, TNFRSF1B, OPRM1, LRP6, 
LRP1B, EPCAM, TRPM2, ARHGAP31, CR1, TMCO4, HEPHL1, CACNA1B, SECTM1, IL15RA, PPAP2A, SLC26A3, IGHV1- 46, 
DPEP2, MYO1B, IL13RA1, ADAM29, JAG1, TTYH1, TMEM144, SCRIB, ITGA11, ATRNL1, PDE6G, MS4A1, GRID2IP, RRAS2, 
IGLV3- 25, SLCO5A1, RAET1E, IFI6, RAB33A, KCNJ6, MUC16, NFAM1, TREM1, RELT, GRAMD1C, SLC4A7, MGAM, DLGAP2, 
MSR1, ERBB4, CLECL1, SRGAP2, LRRC37B, SEMA6A, FPR2, SCN3A, PIEZO2, PTPRC, ABCA12, ZAN, CACNB4, PLIN2, ANXA4, 
RBSN, TMEM176A, CD63, SLC13A5, SLC36A4, LILRB4, ADAM8, FCHO1, OTOA
Cytoplasm PLA2G16, PDE1C, ARHGEF10L, CLIP4, WNK2, NLRP13, CTH, USP13, KRT23, MYH4, GDPGP1, PRG3, TTLL4, GYS1, GSDMA, NAF1, 
MYO7A, UNC13C, SPATA21, CAMSAP1, PLEKHS1, ARHGEF26, PRKAA2, OAS3, GAS2, ASZ1, RGS7, KIF20A, APAF1, KLHL22, 
GALK1, MYO10, SAC3D1, SCLT1, FRY, DNAH8, CHORDC1, SPHK2, RPL38, CNKSR2, TANC2, CDC45, SACS, SEPT14, CCNG2, 
HS3ST1, PTPN13, DIAPH3, FAM49B, RPLP2, EPB41L4A, GPALPP1, RPS21, PIWIL3, RPLP1, SLFN13, HOOK2, RPL27, PSMB7, 




GALNTL6, SNX24, CCZ1B, CFTR, YIF1A, CCDC51, POMT2, LDAH, ACAP1, STEAP2, TMEM38B, NCS1, PIPOX, ST6GALNAC1, PIGK, 
RETSAT, FAM21C, UBIAD1, SMPD4, SNX14, EMC10, RYR1, GCNT1, VPS18, TRAPPC8, AGPAT9, SNX13
Mitochondria GLDC, ACSM2B, MMAA, GRAMD4, OMA1, SFXN4, TFB1 M, MCCC1, GOT2, COX7B, IDH3B, ATP5G2, ABAT, NDUFB11, COX7C, 
MARC1, SURF1, NDUFC2, CENPBD1P1
Nucleus RORB, ZNF692, NOC4L, DXO, ESRP1, C2orf83, C16orf86, NUF2, NLE1, ZNF234, KIAA0556, ZNF763, ASF1B, FIGN, SH2D6, 
ZNF347, ZCCHC4, NUP35, NOVA1, POLR3H, ZNF343, PELO, CCDC155, TATDN1, ZNF780A, PWP2, IQCA1, CHTF18, 
KIAA0101, AIM1, CDCA5, RHNO1, ZNF174, WDHD1, ZNF543, WDR12, WDFY3, PRIM2, COMMD6, ZMYM5, LRRIQ1, FBXO48, 
DNASE1L3, NCAPD2, PPARG, ZWILCH, ATAD2, MAP2 K6, ZNF154, LYRM1, BRAT1
Secreted COCH, APOC1, TIMP2, TLL2, CDNF, AGR3, GDF11, OVCH1, ADAMTS1, CES4A, CPAMD8, HSD11B1L, LAMA3, S100A8, OSCAR, 
VCAN, CFD, S100A9
Note: Using the Ensembl database the genes upregulated with ploidy were annotated in terms of their localization within the cell. Seventy- eight 
contained transmembrane domains and localized to the cell membrane, 77 were annotated as encoding cytoplasmic proteins, 57 nuclear proteins, 
27 internal membrane proteins, 18 mitochondrial proteins, and 18 secreted proteins and for 104 transcripts there was no localization information 
available. MK, megakaryocyte
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from HSC clusters 1 and 4 with the MKs forming their own trajec-
tory in the dimensionality reduced space (Figure 4D).
3.4  |  Functional potential of MK primed clusters
We then retrospectively analyzed FACS index data and found that 
the cells that belong to different clusters based on transcriptome 
data also show differences based on cell surface markers fluores-
cence intensity (Figure 5A). Clusters 1 and 4 could be distinguished 
on the basis of FSC- A and CD34 with cluster 1 having CD34Lo and 
FSC- AHi, whereas cluster 4 has CD34Hi and FSC- AHi, with FSC- AHi 
enriched for clusters 1 and 4 (Figure 5B). Analysis of top PCA vector 
loadings showed that the cell surface expression of CD34, FSC- A, 
and CD49f drive most of the variance observed between HSCs on 
PC2 and PC3 (Figure 6A).
To characterize the lineage differentiation potential of clusters 
1 and 4, we compared our HSC index FACS profiles with those of 
Belluschi et al,36 who previously determined the lineage potential 
of index sorted single HSCs from human cord blood using an op-
timized single- cell colony- forming cell assay, which supported my-
eloid/erythroid and MK lineage differentiation. We therefore 
transposed index sorting surface marker data from Belluschi 
et al onto Figure 6A (Figure 6B). Although only a few cells from 
Belluschi et al differentiated to form MK colonies (violet triangle, 
Figure 6B), these few cells shared cell surface marker expression 
with HSC clusters 1 and 4 from our work (pink triangle and blue 
triangle, respectively).
3.5  |  MK signature in myocardial infarction
Myocardial infarction has been suggested as a model for stress or 
accelerated thrombopoiesis accompanied by elevated mean platelet 
volume and reticulated platelet count.19 We compared the transcrip-
tomes of MKs obtained from seven individuals with severe coro-
nary disease and recent myocardial infarction in the last 6 months 
(undergoing sternotomy for coronary artery bypass grafting) with 
F I G U R E  3  Unsupervised clustering of early lineage priming in single HSCs. (A) Pearson's correlation map of HSCs in unsupervised 
clusters by distance within the PCA space; dendrograms are formed by hierarchical clustering on the Euclidean distances between cells (B) 
Heatmap of mean- centered normalized and corrected log- expression values for the top 20 marker genes for each cluster. Dendrograms are 
formed by hierarchical clustering on the Euclidean distances between genes (row). Column colors represent the cluster to which each cell is 
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those eight individuals from a non- CAD control group (undergoing 
sternotomy for heart valve replacement). Baseline characteristics 
including demographics, platelet parameters, platelet activation, MK 
numbers, and ploidy distribution are shown in Table S25. Essentially, 
the disease and non- CAD control groups are similar in demograph-
ics, with an increased incidence of statin use and antiplatelet use in 
the myocardial infarction group. There is no significant difference in 
mean platelet volume, reticulated platelet count, or MK ploidy be-
tween the two groups. When a larger clinical cohort was assessed 
for platelet parameters and MK FACs characteristics only without 
transcriptome (baseline characteristics in Table S26 [myocardial in-
farction n = 19, non- CAD controls n = 27]), the same pattern was 
revealed; however, there was an increase in platelet mass in the in-
farct group with increased baseline expression of P- selectin; there 
F I G U R E  4  Developmental trajectories of early lineage priming in single HSCs. (A) Ordering single- cell differentiation between cell 
clusters using Monocle 2. Individual cells are connected by a minimum spanning tree with branch points (thin lines), representing the 
differentiation trajectory and clusters are differentiated by color. (B) Single- cell differentiation trajectory showing expression of MK gene 
signature from DMAP dataset31. Expression of gene signature is indicated by the size of each single cell. (C) Single- cell differentiation 
trajectory showing expression of MEP gene signature from DMAP dataset31. Expression of gene signature is indicated by the size of each 
single cell. (D) Ordering differentiation trajectories between HSC cell clusters using Monocle 2 with the addition of the MK 20- to 100- cell 
pools. HSC clusters and MKs are differentiated by color. HSC, hematopoietic stem cell; MEP, megakaryocyte erythroid progenitor; MK, 
megakaryocyte 
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were again no differences in the MK numbers and ploidy distribution 
between groups (Figure S6).
We sequenced a total of 156 pools of 50 to 100 MKs (irrespec-
tive of ploidy); 101 pools from seven individuals with severe cor-
onary disease and recent myocardial infarction and 55 pools from 
eight non- CAD controls. Differential gene expression analysis re-
vealed 139 upregulated (FDR <0.05; 21 DEG with an FDR <0.00010) 
and 679 downregulated (FDR <0.05; 62 DEG with an FDR <0.0001) 
genes in MKs from patients with severe coronary disease and recent 
myocardial infarction (Tables S27, S28). A number of upregulated 
genes were directly related to platelet activation and proteins se-
creted by the alpha granule including the neutrophil chemoattrac-
tant CXCL7 (PPBP), THBS1, and RAP1B as well as the cell surface 
glutamate receptor GRIA1 (Table 2).
F I G U R E  5  Index sorting of single HSCs. (A) Retrospective analysis of FACS sorting strategy for each individual HSC sorted. Left panel: 
CD34 vs CD38; middle panel: CD90 vs CD45RA; right panel: CD90 vs CD49 f. Individual surface marker expression was normalized. Cluster 
1: red; cluster 2: yellow; cluster 3: green; cluster 4: blue; cluster 5: magenta; cells filtered because of poor quality: gray. (B) Retrospective 
analysis of FACS index data: FSC- A vs CD34 for each HSC sorted. Cluster 1 (red): FSC- AHi CD34Hi; cluster 4 (blue): FSC- AHi CD34Lo; cluster 
2 (yellow): FSC- ALo CD34Hi. Individual surface marker expression was normalized. Cluster 1: red; cluster 2: yellow; cluster 3: green; cluster 4: 





















































































F I G U R E  6  Prospective identification of HSC clusters. (A) Principal component analysis (PC2/PC3) of FACS surface marker expression 
for each individual HSC sorted, including: FSC- A, SSC- A, Lin, CD34, CD38, CD45RA, CD90, CD49 f. Vector loading for FSC- A, CD34, and 
CD49f are shown. Cluster 1: red; cluster 2: olive; cluster 3: green; cluster 4: blue; cluster 5: magenta. (B) Projection of FACS surface marker 
expression of HSCs characterized by differentiation assay and their lineage output from Belluschi et al36 onto Figure 6A. As in Figure 6A: 
cluster 1: red; cluster 2: olive; cluster 3: green; cluster 4: blue; cluster 5: magenta. Differentiation assay outputs: erythrocyte: yellow; MK: 
violet; multipotent progenitor: pink; myelocyte: gray. Shaded areas: red: cluster 1; blue: cluster 4; yellow: erythrocyte output; violet: MK. 
The violet triangle in the middle of the figure shows the HSCs from Belluschi et al that formed MKs. The blue shaded area encompasses 
the position of cells in cluster 4; the pink shaded area encompasses the position of the cells in cluster 1. FACS, fluorescence- activated cell 
sorting; HSC, hematopoietic stem cell; MK, megakaryocyte 
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4  |  DISCUSSION
Here, we used full- transcript single- cell and low- input RNA sequenc-
ing to characterize the stages of human bone marrow MK polyploidi-
zation and chart their transcriptional journey from HSC early lineage 
priming, where we identified two separate MK primed clusters.
Our work presents the first interrogation of the transcriptional 
landscape of human bone marrow MKs. The knowledge of the MK 
transcriptome until now being based largely on in vitro– derived 
MKs from CD34+ cells.2- 6,40- 43 There has, however, been some re-
cent work on primary bone marrow MK in mouse and primary MK 
progenitors but not MKs in human.44,45 We charted transcriptional 
changes in human bone marrow MKs through different stages of 
polyploidization. Microarray data of increasing ploidy in in vitro– 
derived MKs previously showed an overall pattern of upregulation 
of genes involved with platelet, coagulation, and hemostatic path-
ways and a downregulation of cell cycle– associated genes.5 Our data 
instead provide a model of MK development and polyploidization 
whereby two distinct transcriptional states exist for low- and high- 
ploidy MKs and the cells transition from one to the other with suc-
cessive endomitotic replication. With increasing ploidy, we observed 
a downregulation of genetic programs related to platelet functional-
ity, although these genes are still transcribed and remain expressed 
within the higher ploidy MKs. Additionally, with increasing ploidy 
level, we observed a marked upregulation of genes encoding ribo-
somal subunits, those associated with protein translation, and pro-
tein localization. These findings suggest that at lower ploidy levels, 
many of the proteins that are transcribed relate to platelet function 
and platelet and MK cell- surface expression. However, at higher 
ploidy levels, energy is redirected to messenger RNA translation and 
appropriate localization of the newly generated proteins into alpha 
granules, dense granules, and other vesicles, readying the cell for 
thrombopoiesis. Bone marrow MKs’ high- energy requirement, par-
ticularly those of higher ploidy, is the likely explanation for the high 
levels of genes involved in cellular metabolism since the production 
of ribosomes consumes large amounts of energy.46 Our data are 
in keeping with previously observed changes in MK ultrastructure 
during in vivo maturation. Although stage 2 MKs (low ploidy) have 
free ribosomes, smooth endoplasmic reticulum, and few granules, 
suggesting lower levels of translation, stage 3 MKs (high ploidy) are 
characterized by rough endoplasmic reticulum, formed alpha and 
dense granules, increases in heterochromatin and smaller nucleoli, 
indicating a reduction of transcription.47- 49 The differences ob-
served with previous studies are likely ascribed to the fact that these 
were characterizing the final steps of MK differentiation rather than 
MK maturation.
The identification of genes upregulated with increasing ploidy 
also has implications for improving our understanding of platelet 
release and potential therapeutic implication for in vitro platelet 
production. Currently, the number of platelets produced for each 
in vitro– generated MK is ~3 log orders lower than what observed 
in vivo, which severely hinder platelet production for clinical trans-
fusion using induced pluripotent stem cell– derived MKs.50 This is 
likely a direct result of the differences between MKs produced in 
culture from pluripotent stem cells and MKs in the bone marrow 
niche in terms of ploidy level, cytoplasmic maturation, or extracel-
lular signals. A number of genes upregulated with increasing ploidy 
were identified to encode transmembrane receptors (PTGER2, 
TNFRSF1B, IL13RA1, and PPAP2A), which upon binding to their li-
gands, might modulate functional effects such as MK chemotactic 
migration from the osteoclastic niche to the vascular sinusoidal 
space or indeed initiate platelet production. These may represent 
important novel drivers of MK maturation and platelet release. 
PTGER2, the G- protein coupled receptor for prostaglandin E2 
known to be present on the platelet membrane, is an important 
regulator of HSC expansion and function in the bone marrow 
niche51 and has been shown to specifically promote MK lineage 
recovery after radiation injury in mouse.52 Binding of TNFRSF1B 
Localization
Upregulated Genes in MK Pools from Myocardial Infarction 
Compared with Non- CAD Control
Cell membrane BCAM, TMEFF2, GNG11, DUOX2, MARVELD2, NCMAP, NLGN4Y, 
RAP1B, COLCA1, TSPAN10, GRIA1, MOG, FAT3, SGCD, 
HSD17B2, RND1, NFASC, KCNIP4
Cytoplasm CFAP74, SAMD4A, RPE65, TRIM2, EIF4ENIF1, NME2, MTMR7, 
PMP2, DPF1, TUB, PRKCI, TEX14, FUT6, CABP1, SPIRE2, 
MMACHC
Internal membrane FITM2, LAPTM4B, TMEM130, ARMC10, THBS1, ELOVL7
Mitochondria ECHDC3, KIAA0391, COQ3, TOMM70A
Nucleus TIAF1, ZNF732, CASZ1, CHEK1, DZIP1, RAD51B, SUV420H2, 
HIST1H2BJ
Secreted MTRNR2L12, HMCN2, PPBP, PRELP, OLFML2A, C7, GREM1, SPX, 
IGHG4
Note: Using the Ensembl database the genes upregulated with ploidy were annotated in terms of 
their localization within the cell. Eighteen contained transmembrane domains and localized to the 
cell membrane, 16 were annotated as encoding cytoplasmic proteins, 8 nuclear proteins, 6 internal 
membrane proteins, 4 mitochondrial proteins, and 9 secreted proteins and for 78 transcripts there 
was no localization information available. MK, megakaryocyte
TA B L E  2  MK transcripts upregulated in 
myocardial infarction: localization within 
the cell
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by TNF- A, also present on the platelet membrane, suppresses 
apoptosis and has been shown to induce megakaryopoiesis in 
hematopoietic progenitors, which could, in part, account for in-
creased platelet mass in inflammation.17 IL13RA1 mediates the 
effects of IL13, which significantly increase MK colony formation 
in vitro53 and in murine models.54 PPAP2A is an integral membrane 
glycoprotein that degrades lysophosphatidic acid by dephosphor-
ylation. Lysophosphatidic acid gradient has been proposed in 
regulating localization within the osteoclastic niche and has been 
shown to inhibit megakaryopoiesis in vitro.55 Future work on these 
transmembrane receptors and their ligands, to investigate their 
role in MK maturation, would be imperative in increasing the ef-
ficiency of in vitro platelet production from induced pluripotent 
stem cell– derived MKs.
To investigate the origin of the MK, we identified five tran-
scriptionally distinct HSC subsets in human bone marrow sup-
ported by two independent clustering methods. Two of these 
subsets (clusters 1 and 4) displayed transcriptional priming toward 
the MK lineage; when overlaid onto data from single- cell assays,36 
they showed a functional MK lineage bias. Cells in these two clus-
ters expressed genes that have been shown to be expressed in the 
MK- platelet lineage.3,6,31,38 The high proportion of HSCs display-
ing priming to the MK lineage is in keeping with existing evidence 
indicating that this is the first lineage bifurcation in the multipo-
tent HSC compartment7- 11 and the role of MKs in HSC regulation 
within the stem cell niche.56- 58 Plotting these cells in pseudotime 
differentiation trajectories showed that clusters 1 and 4 in fact 
branch from the same trajectory. Comparison with other data-
sets6,31 demonstrated that, although cells in cluster 1 were en-
riched for genes involved in HSC function, megakaryopoiesis and 
genes commonly expressed between MK and MEP populations, 
cells in cluster 4, in contrast, were enriched for genes specific to 
MKs with a number of marker genes for this cluster directly re-
lated to platelet function. We recreated a differentiation trajec-
tory combining the HSCs and MKs transcriptomic data together 
and showed that human bone marrow MKs branch directly from 
phenotypic HSCs, specifically cells in clusters 1 and 4 supporting 
the notion of transcriptional priming of these clusters toward the 
MK lineage. Because HSCs in cluster 1 display gene expression 
common to intermediate progenitors as well as MKs, we hypothe-
size that these may be primed for MK differentiation via a classical 
differentiation pathway, whereas HSCs in cluster 4 might be those 
that exhibit direct MK differentiation bypassing the classic MEP, 
which has been shown in several studies.7- 11 It is also possible that 
these two HSC clusters may give rise to two phenotypically differ-
ent types of mature MKs.
We also compared MK transcriptional signatures in myocardial 
infarction as a model for stress thrombopoiesis with non- CAD con-
trols. Despite finding no significant differences in platelet parame-
ters and MK ploidy in myocardial infarction, our data showed that a 
number of genes upregulated in MKs from individuals with severe 
coronary disease and myocardial infarction compared with non- CAD 
controls were related to thrombus formation, such as PPBP, the gene 
encoding chemokine CXCL7, which plays a critical role in leukocyte 
migration through thrombi by binding its receptor CXCR1/2 on neu-
trophils and other leukocytes.59,60 Similar higher levels of thrombo-
spondin 1 (THBS1) have been found to be associated with peripheral 
artery disease and RAP1B that encodes a small GTP- binding protein 
involved in outside- in signalling via the collagen receptor integrin 
alpha2- beta1 (CD49b/29) on platelets; it also plays an important 
role in the cross- talk between alpha2- beta1 and integrin alphaIIb/
beta3 (CD41/61), the receptor for fibrinogen on MKs and platelets.61 
Hence, RAP1B has been suggested as a potential therapeutic tar-
get for a novel class of platelet inhibitors in myocardial infarction.62 
There is now compelling evidence for enhanced megakaryopoiesis 
as a pathogenic driver for atherosclerosis and myocardial infarc-
tion.63,64 The clinical trial CANTOS65 demonstrated improved car-
diovascular outcomes in patients with myocardial infarction with 
Canakinumab, a monoclonal antibody targeting IL1B, a known driver 
of megakaryopoiesis both in vitro and in vivo.66 We found that the 
gene encoding the AMPA glutamate receptor, GRIA1, was upregu-
lated in MKs in individuals with myocardial infarction. As glutamate 
serum levels are increased in thrombosis67 and interruption of glu-
tamate binding to the NMDA glutamate receptor in megakaryocyte 
cell lines resulted in impaired megakaryopoiesis68; this observation 
raises the possibility of a positive feedback mechanism of glutamate 
signaling leading to increased platelet production perpetuating a 
prothrombotic state. Therefore, our data also support a pathological 
role of stress thrombopoiesis in acute coronary thrombosis.
Limitations of this transcriptional study should be acknowledged, 
including the baseline characteristics of the patient populations. 
Advanced age leading to clonal hematopoiesis, male predominance 
particularly in the myocardial infarction group, and statin and anti-
platelet use can all lead to changes in gene expression.
Taken together, our work charts the transcriptional journey from 
MK lineage commitment through to the mature polyploid MK, de-
scribes 2 HSC subpopulations exhibiting MK lineage priming and di-
rect branching of MK differentiation from these HSC subpopulations 
bypassing intermediate progenitors such as the MEP. Furthermore, 
the MK transcriptional changes in the setting of myocardial infarc-
tion are then explored. Ultimately, better understanding of MK lin-
eage commitment, differentiation from the HSC, polyploidization, 
and platelet release are key to deciphering pathological modulation 
leading to thrombosis and bleeding disorders.
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